论文部分内容阅读
目的探讨非酒精性脂防肝的综合治疗。方法回顾分析本科收治的60例患者的临床资料。结果本组60例脂肪肝经治疗均程度减轻,血脂、血糖下降,体质量减轻,好转出院。无一例并发症,无死亡病例。结论随着生活水平的提高非酒精性脂肪肝的发病率在增加,但就诊患者较少。临床医师对于肥胖患者,应高度重视,如肝功反复异常,血清酶及血脂升高,又排除临床常见的病毒感染的患者,除常规行腹部B超检查外,有条件应选择性行肝穿活检术,尽早明确诊断、评判肝组织炎症活动度及纤维化程度,为临床治疗提供有力的证据,以及时作出诊断,尽早给予综合治疗。
Objective To explore the comprehensive treatment of non-alcoholic lipids and anti-liver. Methods The clinical data of 60 patients admitted to our hospital were retrospectively analyzed. Results The group of 60 cases of fatty liver treatment were alleviated, blood lipids, blood glucose decreased, weight loss, improved discharge. No complications, no deaths. Conclusion With the improvement of living standard, the incidence of non-alcoholic fatty liver disease is increasing, but there are fewer patients. Clinicians should attach great importance to obese patients, such as recurrent liver abnormalities, elevated serum enzymes and blood lipids, and rule out common clinical viral infection in patients, in addition to the routine line of abdominal B-ultrasound, the conditions should be selective liver Biopsy, as soon as possible a clear diagnosis, assessment of liver inflammation activity and degree of fibrosis, to provide strong evidence for clinical treatment, and make timely diagnosis, comprehensive treatment as soon as possible.